CODAC is pleased to announce recent leadership changes at its 24/7 outpatient substance use treatment center, which has been named a Center of Excellence and 24/7 Entry Point. This center provides integrated care for individuals seeking treatment for all drug and alcohol use – including medication assisted treatment for those in recovery from opioid addiction (including fentanyl, heroin, morphine, oxycontin, and others) – through the use of FDA-approved medications, psychiatry, primary care, therapy, acupuncture, wellness classes, peer support and more.
Mark Grant, MD has been named Medical Director of CODAC’s Medication Assisted Treatment Program
Since joining CODAC as an Addictions Fellow and then as Associate Medical Director, Mark Grant, MD has immersed himself in the world of Addiction Medicine. He has a track record of proven leadership and clinical care, a heart for underserved populations and individuals with mental illness and substance use disorders, and a passion for growth. “We are confident in his ability to lead our medical operations with excellence and dedication,” says Dennis Regnier, CODAC President & CEO.
As Medical Director of CODAC’s Medication Assisted Treatment program, Dr. Grant oversees clinical operations, ensuring the delivery of high-quality, evidence-based care to individuals with opioid- and other substance use disorders. He is responsible for developing treatment protocols, supervising medical staff, ensuring compliance with regulatory standards, and creating an environment where person-first integrated care is provided to promote positive outcomes.
“I am incredibly excited and fortunate to take on the role of medical director at CODACs medication assisted treatment program,” says Dr. Grant. “For years, this clinic has been setting the bar high in the Tucson community, providing community members with patient-centered and innovative programs such as 24/7 services, integrated care and hepatitis C treatment.
“While the need unfortunately continues to grow, I am looking forward to taking on the challenge with the incredible team at CODAC who consistently demonstrates their willingness to go above and beyond to serve our patients and pursue excellence.”
Larry Oñate, MD is transitioning to Best Practices and Innovation Advisor
Larry Oñate, MD has transitioned out of direct administrative and clinical services at CODAC to take on a new consulting role for the organization. Leveraging his extensive expertise in addiction medicine, Dr. Onate’s role now focuses on researching and understanding community and national trends in substance use and treatment. He will be analyzing trends and emerging practices and following constantly evolving federal regulations to be able to provide expert consultation both at CODAC and around the country to enhance substance use treatment service delivery.
